Skip to content
2000
Volume 17, Issue 23
  • ISSN: 0929-8673
  • E-ISSN: 1875-533X

Abstract

Positron emission computed tomography (PET) is a functional, noninvasive method for imaging regional metabolic processes that is nowadays most often combined to morphological imaging with computed tomography (CT). Its use is based on the well-founded assumption that metabolic changes occur earlier in tumors than morphologic changes, adding another dimension to imaging. This article will review the established and investigational indications and radiopharmaceuticals for PET/CT imaging for prostate cancer, bladder cancer and testicular cancer, before presenting upcoming applications in radiation therapy.

Loading

Article metrics loading...

/content/journals/cmc/10.2174/092986710791556014
2010-08-01
2025-04-16
Loading full text...

Full text loading...

/content/journals/cmc/10.2174/092986710791556014
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test